The potential of apolipoprotein mimetic peptides in the treatment of atherosclerosis

about

The potential of apolipoprotein mimetic peptides in the treatment of atherosclerosis

Item

http://www.wikidata.org/entity/Q40492051

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

The potential of apolipoprotein mimetic peptides in the treatment of atherosclerosis

@en

type

Item

label

The potential of apolipoprotein mimetic peptides in the treatment of atherosclerosis

@en

prefLabel

The potential of apolipoprotein mimetic peptides in the treatment of atherosclerosis

@en

P1476

The potential of apolipoprotein mimetic peptides in the treatment of atherosclerosis

@en

P2093

Luke J Leman

http://www.w3.org/2001/XMLSchema#string

P2860

High-density lipoprotein and 4F peptide reduce systemic inflammation by modulating intestinal oxidized lipid metabolism: novel hypotheses and review of literature

Two adjacent domains (141-150 and 151-160) of apoE covalently linked to a class A amphipathic helical peptide exhibit opposite atherogenic effects.

Structure/function relationships of apolipoprotein a-I mimetic peptides: implications for antiatherogenic activities of high-density lipoprotein.

In vivo efficacy of HDL-like nanolipid particles containing multivalent peptide mimetics of apolipoprotein A-I.

Apolipoprotein A-I mimetics.

Treatment of patients with cardiovascular disease with L-4F, an apo-A1 mimetic, did not improve select biomarkers of HDL function.

A novel apolipoprotein C-II mimetic peptide that activates lipoprotein lipase and decreases serum triglycerides in apolipoprotein E-knockout mice

Intestine may be a major site of action for the apoA-I mimetic peptide 4F whether administered subcutaneously or orally.

D-4F, an apoA-I mimetic peptide, inhibits proliferation and tumorigenicity of epithelial ovarian cancer cells by upregulating the antioxidant enzyme MnSOD.

D-4F-mediated reduction in metabolites of arachidonic and linoleic acids in the small intestine is associated with decreased inflammation in low-density lipoprotein receptor-null mice

P304

215-217

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/CLP.15.18

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Luke Leman

P577

2015-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27110290

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

4840888

http://www.w3.org/2001/XMLSchema#string